Newly developed molecular target anticancer drugs have shown
remarkable efficacy even in the treatment of intractable cancers
such as hepatoma and renal cell carcinoma. As cancer research is
becoming a multidisciplinary endeavor, close cooperation across the
basic, translational, and clinical research fields holds the
promise of further advances in cancer therapeutics. This book sets
forth new strategies for development: cancer therapy targeting
receptor tyrosine kinases with clinical utilization of new
signaling regulations; interaction between cancer progression and
extracellular environments such as inflammatory cytokines and the
extracellular matrix; and investigation of biomarkers for
personalized cancer therapy, with microarray analysis and
pharmacogenomics technology. These and other findings from the
latest investigations into cancer cell biology and therapeutics
make this book an invaluable source for investigators in both the
clinical and basic cancer research fields.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!